8-K: Vireo Growth Inc. Reports Record Revenue, Gross Profit Margin, and Operating Income for Fiscal Year 2024

Vireo Growth Inc. achieved record financial performance in 2024, driven by a 15.4% increase in revenue excluding discontinued operations and strategic growth initiatives.

Summary

• Vireo Growth Inc. announced its financial results for the fourth quarter and full year ended December 31, 2024.
• The company achieved record revenue, gross profit margin, and operating income in fiscal year 2024.
• FY24 revenue reached $99.4 million, a 15.4% increase year-over-year excluding discontinued operations.
• Fourth quarter 2024 revenue was $25.0 million, up 3.5% year-over-year and flat sequentially.
• The company ended fiscal year 2024 with $91.6 million in cash after closing a private placement in December.
• Pending merger transactions, recent equity raise, and growth catalysts position the company for a transformational 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with record financial results and strategic initiatives for future growth. While there are some negative aspects, the overall tone is optimistic.

Positives

• Record revenue, gross profit margin, and operating income were achieved in fiscal year 2024.
• Revenue increased by 15.4% year-over-year excluding discontinued operations.
• Gross profit margin improved to 51.1% for the full year.
• Adjusted EBITDA increased by 28.4% compared to the previous year.
• The company has a strong cash position of $91.6 million.
• A private placement offering raised gross proceeds of approximately $81 million.
• The company is positioned for a transformational 2025 with pending merger transactions and growth catalysts.

Negatives

• Fourth quarter results were impacted by one-time transaction expenses of $4.2 million related to pending merger transactions.
• Operating income margin decreased to (3.4)% for the fourth quarter, a (2,560) bps decrease.
• The company reported a net loss of $28.0 million for the year ended December 31, 2024.

Risks

• The company's pending mergers are subject to shareholder and regulatory approvals, and there is no guarantee they will close.
• The company's future performance is subject to various risks and uncertainties, including market conditions, regulatory environment, and competition.
• The company's ability to meet the demand for flower in Minnesota is a risk factor.
• The company faces the risk of failure in the lawsuit with Verano and the cost of that litigation.
• The company's ability to dispose of its assets held for sale at an acceptable price or at all is a risk.

Future Outlook

The company expects a transformational year in 2025, driven by pending merger transactions, growth investments in legacy markets, and the launch of adult-use sales in Minnesota.

Management Comments

• CEO John Mazarakis stated that the company is pleased to deliver record revenue, gross margin, and operating income in 2024.
• Mr. Mazarakis noted that fourth quarter results were impacted by one-time transaction expenses, but the company remains pleased with continued strength in operating performance.
• Mr. Mazarakis believes the company is building a portfolio of prolific brands and local operators, and is positioned well to capitalize on an attractive platform for growth.
• CFO Tyson Macdonald stated that the company is pleased to close the year in a strong financial position and confident in its ability to drive strong returns for shareholders.
• Mr. Macdonald believes the company's liquidity position will help support improved access to capital in the future.

Industry Context

Vireo's performance reflects the broader trend of growth in the cannabis industry, particularly in states with expanding medical and recreational markets. The company's strategic focus on mergers and acquisitions aligns with the industry's consolidation trend, as companies seek to expand their market presence and achieve economies of scale.

Comparison to Industry Standards

• Compared to companies like Curaleaf and Trulieve, Vireo's revenue is smaller, but its growth rate is competitive.
• Vireo's gross margin of 51.1% is in line with industry averages for vertically integrated cannabis companies.
• The company's adjusted EBITDA margin of 25.3% is comparable to other leading cannabis operators.
• The $81 million private placement provides Vireo with capital to pursue growth opportunities, similar to how other companies have used capital raises to fund expansion.

Stakeholder Impact

• Shareholders can expect strong returns given the many high ROI opportunities across the company's portfolio.
• Employees may benefit from growth opportunities and investments in the company's operations.
• Customers can expect continued innovation and investment in growth opportunities.
• The company's strong financial position will help support improved access to capital in the future.

Next Steps

• The company expects to close its pending merger transactions sometime in calendar year 2025, pending shareholder and regulatory approvals.
• Management expects to provide updates on the closing process to investors as more information becomes available.
• The company intends to use the net proceeds from the private placement offering for business development, including organic and acquisitive growth investments, as well as working capital and general corporate purposes.

Key Dates